AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: NCT02630290
Drug: Ropivacaine
RxNorm normalized name: Ropivacaine
DrugBank: Ropivacaine (DB00296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided supraclavicular brachial plexus block with 0.5% ropivacaine
Trial: NCT02630290
Drug: Ropivacaine + Dexmedetomidine
DrugBank: Ropivacaine (DB00296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided supraclavicular brachial plexus block with 0.5% ropivacaine plus low-dose (30 microg) dexmedetomidine
Trial: NCT00386646
Drug: 0.5% carboxymethylcellulose (CMC) with purite and CMC alone
DrugBank: Carboxymethylcellulose (DB11059)
FDA approved: no
EMA approved: no
PMDA approved: no